Skip to content
What We Do
For Providers
Model-Informed Precision Dosing
Clinical Decision Support
Real-Time Clinical Analytics
Infectious Disease
Bone Marrow Transplant
Other Therapeutic Areas
Customers
For Life Sciences
Precision Dosing in Clinical Trials
Real-time Pharmacology Analytics in Clinical Trials
Companion Applications
How We Do It
InsightRX Nova
InsightRX Apollo
Continuous Learning
Integrations
Drug Modules
Security
Company
Mission & Values
Leadership
Careers
Press Releases
Press Releases
Media
Resources
Product Innovation
Scientific Publications
Thought Leadership
White Papers
Contact Us
FEATURED
Beyond Vancomycin: Why Linezolid & Daptomycin Call for Precision Dosing
Press Releases
Media
Dec 16, 2021
Dosages Can Be Tailored To Individuals For Safety And Efficacy
Press Releases
Oct 5, 2021
InsightRX Selected For Inaugural Cohort In Cutting-Edge Innovation Hub To Transform Cancer Care
Press Releases
Sep 14, 2021
Saladax Biomedical And InsightRX To Present Chemotherapy Drug Outcomes At International Congress In September
Press Releases
Aug 26, 2021
InsightRX Receives CE Mark For Nova Software, Allowing It To Expand Precision Dosing Capabilities In Europe
Press Releases
Aug 14, 2021
Hospital Precision Dosing Is Ramping Up
Press Releases
Jun 8, 2021
InsightRX’s Precision Medicine Platform Integrated Into Sentara Healthcare EHR To Help Safely Administer Vancomycin Doses For Treatment Of Infections
Media
Mar 10, 2021
Five Minutes In Healthcare — Featuring Sirj Goswami
Press Releases
Dec 22, 2020
InsightRX Adds Renowned Pharmacology Experts Drs. Richard Peck And Michael Rybak To Its Scientific Advisory Board
Press Releases
Jul 30, 2020
New Study Co-Authored By InsightRX Shows Model-Informed Precision Dosing Could Improve Efficacy Of Hematopoietic Cell Transplants While Reducing Toxicity
PREV
1
2
3
4
5
NEXT
